摘要
目的:分析盐气溶胶疗法在慢性支气管炎呼吸康复中的应用价值。方法:选取125例慢性支气管炎患者,按照随机数字表法分为对照组和观察组。对照组60例,采用常规药物治疗及呼吸康复训练,观察组65例,采用常规药物治疗结合盐气溶胶疗法,比较两组治疗前后的炎症因子、免疫指标、血气指标及呼吸功能改善情况。结果:治疗后,观察组EOS、IL-6、PCT、IgE、IgM、IgA均低于对照组,差异有统计学意义(P<0.05)。治疗后,观察组动脉氧分压(PO_(2))高于对照组,二氧化碳分压(PaCO_(2))低于对照组(P<0.05)。治疗后,观察组的第一秒用力呼气容积百分比(FEV_(1))、用力肺活量(FVC)高于对照组,呼吸频率(RR)低于对照组(P<0.05)。结论:盐气溶胶疗法能显著改善慢性支气管炎患者的炎症反应、免疫功能及动脉血气指标,对促进呼吸功能康复有重要意义。
Objective:To analyze the application value of salt aerosol therapy in respiratory rehabilitation of chronic bronchitis.Methods:125 patients with chronic bronchitis were selected and randomly divided into the control group and observation group according to a random number table method.The control group consisted of 60 patients who were received routine drug treatment and respiratory rehabilitation training,while the observation group consisted of 65 patients who were received routine drug treatment combined with salt aerosol therapy.The inflammatory factors,immune indicators,blood gas indicators,and respiratory function improvement before and after treatment were compared between the two groups.Results:After treatment,the EOS,IL-6,PCT,IgE,IgM,and IgA levels in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the arterial oxygen partial pressure(PO_(2))of the observation group was higher than that of the control group,while the partial pressure of carbon dioxide(PaCO_(2))was lower than that of the control group(P<0.05).After treatment,the first second forced expiratory volume percentage(FEV_(1))and forced vital capacity(FVC)of the observation group were higher than those of the control group,and the respiratory rate(RR)was lower than that of the control group(P<0.05).Conclusion:Salt aerosol therapy can significantly improve the inflammatory reaction,immune function and arterial blood gas index of chronic bronchial patients,which is of great significance in promoting the recovery of respiratory function.
作者
盛彩玲
王苏
SHENG Caiing;WANG Su(Dept.of General Medicine,First People′s Hospital of Shangqiu City,Shangqiu 476100,China)
出处
《华夏医学》
CAS
2023年第6期60-65,共6页
Acta Medicinae Sinica
基金
河南省医学科技攻关项目(LHGJ2021012156)。
关键词
慢性支气管炎
盐气溶胶
呼吸康复
应用价值
chronic bronchitis
salt aerosol
respiratory rehabilitation
application value
